A carregar...
Zoledronate and Raloxifene combination therapy enhances material and mechanical properties of diseased mouse bone
Current interventions to reduce skeletal fragility are insufficient at enhancing both the quantity and quality of bone when attempting to improve overall mechanical integrity. Bisphosphonates, such as Zoledronate (ZOL), are used to treat a variety of bone disorders by increasing bone mass to decreas...
Na minha lista:
| Publicado no: | Bone |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7036744/ https://ncbi.nlm.nih.gov/pubmed/31233931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2019.06.018 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|